Multiple Sclerosis Trial, By Invitation NCT06955962 Sponsor: Karadeniz Technical University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT06955962
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Living in the city centre of Trabzon
  • Diagnosed with Multiple Sclerosis (MS) at least six months ago
  • Has not had an MS relapse (flare-up) in the past three months
  • Currently receiving MS treatment as an outpatient (not staying in hospital)
  • Able to read and write
  • Has no previous experience with mandala (a type of structured drawing or colouring activity)
  • Not currently taking part in any form of art therapy
  • Has no difficulties with communication or perception

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Has had an MS relapse (flare-up) within the past three months
  • Currently receiving MS treatment as an inpatient (staying in hospital)
  • Aged 18 years or younger
  • Has a physical disability that would prevent participation in the mandala activity
  • Currently taking part in any form of art therapy
  • Has difficulties with communication or perception
  • Has a diagnosed psychiatric (mental health) condition
  • Cannot be contacted by phone call or text message
  • Has an allergy to any of the materials used in the mandala therapy sessions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Karadeniz Technical University
Registry
ClinicalTrials.gov
Start date
10 May 2025
Est. completion
10 July 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Quality of life of patient with MS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov